日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander Activity

奥瑞他汀S:一种耐受性更佳且旁观者活性有所改变的奥瑞他汀有效载荷

Moquist, Philip N; Eng-Duncan, Nicole M-L; Bovee, Tim D; Snead, Katie; Bou, Lauren; Zhang, Xinqun; Blackburn, Brittney; Wright, Jennifer; Simmons, Jessica K; Neff-LaFord, Haley D; Senter, Peter D; Doronina, Svetlana O

The Vedotin Antibody-Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles

Vedotin抗体-药物偶联物有效载荷驱动基于平台的非临床安全性和药代动力学特征分析

Neff-LaFord, Haley D; Carratt, Sarah A; Carosino, Christopher; Everds, Nancy; Cardinal, Kristen A; Duniho, Steven; Schutten, Melissa M; Frantz, Christopher; Zuch de Zafra, Christina; Harstad, Eric B

Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation

抗体效应功能的可逆化学修饰可减轻不必要的全身免疫激活

Philip N Moquist, Xinqun Zhang, Chris I Leiske, Nicole M-L Eng-Duncan, Weiping Zeng, Noah A Bindman, Serena W Wo, Abbie Wong, Clark M Henderson, Karalyne Crowder, Robert Lyon, Svetlana O Doronina, Peter D Senter, Haley D Neff-LaFord, Django Sussman, Shyra J Gardai, Matthew R Levengood